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Abstract
Young female cancer survival rates significantly increased due to the great progress of cancer therapy. In fact, cryostorage and transplantation
of ovarian tissue have already resulted in the birth of healthy babies. Follicle in vitro growth (IVG) has the great potential of restoring fertility
by achieving functional oocytes from the most immature stages to maturation. This is suitable for a wide range of patients, from pubertal
to perimenopause women. Notable achievements have been achieved in human follicle IVG in the past decade. Mature oocytes have been
successfully collected from long‑term sequential follicle IVG. However, it is still a major challenge to establish a stable and efficient follicle
IVG system able to generate mature and competent oocytes. Hereby, we review the approaches being taken so far using ovarian tissue to
support follicle growth at different stages in vitro.
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Introduction
With the remarkable progress achieved in the diagnosis and
treatment of cancer, many cancer patients have obtained a
surpassing survival rate and a better life quality. However,
radiotherapy and chemotherapy, which are the principal
strategies for cancer treatment, have high toxicity to gonads and
lead to diminished ovarian reserve and infertility in women.[1]
Therefore, fertility preservation methods become critical to
preserve the ability of having children in cancer survivors.
There are different fertility preservation strategies to satisfy
the different types of cancer patients, including embryo and
oocyte cryopreservation, ovarian tissue cryopreservation and
transfer, and follicle in vitro culture, some of which are still
at the research level. Embryo and oocyte cryopreservation are
the assisted reproductive techniques used routinely in clinical
practice, but often require ovarian stimulation which may
increase hormone levels, placing hormone‑sensitive cancer
patients in higher risk situations and increasing the waiting
time to undergo cancer treatment. In addition, these techniques
are not suitable for prepubertal patients.[2] Ovarian tissue
cryopreservation and transfer has been successfully reported
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Follicle in vitro growth (IVG) aims to isolate all phases of
follicular development before ovulatory stage from cryopreserved
ovarian tissues and production of the competent oocytes to
follow in vitro maturation (IVM) or in vitro fertilization (IVF).
This is an ideal alternative to avoid reintroduction of malignant
cells into the patients and to potentially increase the number of
oocytes, as there are thousands of various classes of follicles
in ovarian tissues. Moreover, it does not require hormone
stimulation, which is feasible for both reproductive‑age women
and prepubertal children. However, no live births have been yet
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to result in a live birth 2004,[3] and more than 130 babies were
subsequently born by this technique all over the world since
then.[4] Nevertheless, transferring of the cryopreserved ovarian
tissues poses the risk of reintroducing the malignant cells back
to the body, leading to the recurrence of cancer.[4]
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achieved with IVG techniques in humans. There are still several
challenges to overcome before follicle growth can be applied as
an approach for accessing competent oocytes. In recent years,
much progress has been made in establishing IVG approaches
in humans. This review aims to summarize follicle activation
and IVG methods and discusses the prospects as well as the
limitations of applying them in clinical practice.

Human Folliculogenesis
Formation and development of primordial follicles begin in
the fetal phase. This pool of primordial follicles represents a
population of germ cells from which recruitment for growth
occurs throughout the reproductive life of females. Follicular
development involves a series of complex and precisely
regulated biological events consisting of three main distinct
phases: first, formation and beginning of primordial follicles
activation; second, growth of primary follicles with cuboidal
granulosa cells, in which the oocyte experiences a rapid growth
in size; third, rupture of the ovulatory follicle, releasing a
cumulus–oocyte complex at ovulation in response to the
luteinizing hormone surge.[5]
Oocytes arrest at the meiotic stage of prophase I within the
early follicles and must acquire the ability to resume meiosis
and acquire the developmental competence necessary to
support fertilization and embryonic growth. Cell‑to‑cell
bidirectional communication between the oocyte and granulosa
cells is crucial for oocyte competence and correct embryo
fertilization and development.[6]

Primordial Follicle Activation and Growth In vitro
Primordial follicle activation

The majority of follicles in the human ovary are primordial
follicles during the whole individual lifespan.[7] This large
proportion of primordial follicles makes them the most abundant
resource to obtain the fertilizable oocyte. Most of the primordial
follicles are at dormant state before they are recruited to the
growing follicle pool. A primordial follicle encloses a meiotically
arrested oocyte at the dictyate stage of prophase I surrounded by
flattened granulosa cells. Only a small number of these follicles
are recruited for further growth into Graff follicles in each cycle.
The main feature of primordial follicle activation is the change
in morphology of granulosa cells, which change from a flat
shape to cuboidal, initiating oocyte growth.[8] It is very critical
to activate primordial follicles effectively and synchronically to
establish a reliable IVG system. To achieve this goal, extensive
efforts have been made on revealing the mechanism underlying
follicular activation during the past decades. For instance, two
of the major pathways involved in primordial follicle activation,
PI3K-PTEN-AKT-FOXO3-mTOR pathway and the Hippo
signaling pathway have been investigated in the past decades.

PI3K‑PTEN‑AKT‑FOXO3‑mTOR pathway

PI3K‑PTEN‑AKT‑FOXO3‑mTOR pathway is the main
pathway involved in primordial activation. It is based on
PI3K‑AKT‑mTOR pathway which has many molecules,

including kinases, phosphatases, and transcription factors that
regulate cell proliferation, apoptosis, growth and metabolic
activity.[9] In the previous studies, phosphatase and tensin
homolog (PTEN) and forkhead box O‑3 (FOXO3) have been
revealed to regulate primordial activation with the coordination
of PI3K‑AKT‑mTOR pathway. The mechanism of this pathway
involved in mammalian primordial follicle activation has been
reviewed comprehensively in the past[10,11] and is summarized
briefly in Figure 1a.

The Hippo signaling pathway

The Hippo pathway has been identified to have a pivotal role
in growth regulation and suppress the overgrowth of organs.[12]
It consists of a serine/threonine protein kinase cascade that
includes several negative growth regulators which dispute the
key transcriptional coactivators, Yes‑associated protein (YAP),
and transcriptional coactivators PDZ‑binding motif (TAZ) to
achieve the nuclear access.[13] When the Hippo pathway is
disrupted, YAP phosphorylation is inhibited and results in the
accumulation of dephosphorylated form of YAP in the nucleus,
which enhances the CCN growth factors and expression of
other transcription factors.[14] Details of Hippo pathway with
follicle activation are summarized in Figure 1b.

Primordial follicle growth in vitro

Multiple studies have investigated human primordial follicle
activation and growth by manipulating the involved pathways.
One of the star molecules is PTEN inhibitor. Liu et al.
incubated human ovarian cortex strips with PTEN inhibitor
in vitro for 24 h and found that primordial follicles were
activated and led to mature oocytes after xenotransplantation
into immunodeficient mice.[15] Likewise, other studies showed
that the PTEN inhibitor increased activation of primordial
follicles, while compromising development of growing
follicles in the ovary.[16] Sun et al. proposed an alternative
approach with mammalian target of rapamycin (mTOR)
and phosphatidylinositol‑3‑kinase (PI3K) stimulators which
increased the human growing follicles in ovarian cortex with
histological analysis.[17] Notably, Kawamura et al. treated
primary ovarian insufficiency patients by fragmenting ovaries
followed by Akt stimulator treatment and autografting.
Follicular growth was successfully promoted, and the first
live births were announced after IVF‑ET with the mature
egg collected after the treatment.[14] Following this study,
several groups had succeeded in achieving live births either
with cryopreserved[18] or fresh tissues.[19] In the most recent
study, PI3K/Akt activators, mTORC1 inhibitor, and Hippo
signaling pathway disruption were compared in human ovarian
cortex, confirming that PI3K/Akt pathway and Hippo pathway
accelerate primordial follicles recruitment while mTORC1
inhibitor partially prevents massive spontaneous activation.[20]

Developmental Follicle Growth In vitro
Isolation of follicles

Follicle isolation is one of the crucial steps toward follicle IVG.
The most challenging part is how to effectively isolate follicles
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Figure 1: Pathways in primordial follicle activation (adapted from ). (a) PI3K‑PTEN‑AKT‑FOXO3‑mTOR pathway in primordial follicle activation. The
initiating factors of this process are largely unknown. Upgraded Kit legand from GCs of primordial follicle binds to its KIT/tyrosine kinase receptor, KIT on
the surface of oocyte and activate the PI3K complex.[65] PI3K complex convert PIP2 to PIP3 which is the key element of PI3K pathway and activate the
nuclear translocation and phosphorylate AKT (p‑AKT).[66,67] p‑AKT enhances primordial follicle activation by inhibition of the phosphorylation of FOXO3a[68]
as the deletion of FOXO3a initiated the activation of primordial follicle in mouse model.[69,70] p‑AKT activates mTOR complex 1 (mTORC1) by inhibiting
tuberous sclerosis complex 1/2 (TSC1/2, or tuberin). mTORC1 then phosphorylates S6K which activates S6 to phosphorylates S6 as a sequence. Also,
mTORC1 inhibits the phosphorylation of 4EBP1, which functions together with p‑S6 are highly involved in cell growth and proliferation.[71,72] PTEN is the
regulator to convert PIP3 to PIP2 and which keep the primordial follicle as dormant.[73,74] PDK1 is a master kinase, which is another regulator for the
activation of AKT/PKB and many other AGC kinases.[75] PI3K‑mediated signaling partially converges at PDK1. PDK1 activates AKT via phosphorylating
AKT at T308.[68] (b) The Hippo signaling pathway in primordial follicle activation. Ovarian tissue fragmentation transforms G‑Actin to F‑Actin by
inducing the actin polymerization which disrupts the Hippo signaling pathway by decreasing the expression of MST1/2 and SAV1 complex.[5] It then
phosphorylates LATS1/2 which inhibit the phosphorylation YAP and TAZ, two major downstream effectors of the Hippo pathway. Dephosphorylated YAP/
TAZ translocate into the nucleus and interact with the transcription factors such as TEAD1‑4 then stimulate the expression of downstream CCN growth
factors and BIRC apoptosis inhibitors, leading to initiates primordial follicle activation and development.[20] PI3K: Phosphatidylinositol‑3‑kinase; AKT:
Protein kinase B; mTOR: Mammalian target of rapamycin; GC: Granuloca cells; KIT: KIT Proto‑Oncogene Receptor Tyrosine Kinase; mTORC1: Target
of Rapamycin complex 1; 4EBP1: 4E‑Binding Protein 1; PIP3: Phosphatidylinositol 3,4,5 trisphosphate; PIP2: Phosphatidylinositol (4,5)‑bisphosphate;
PDK1: 3‑Phosphoinositide‑dependent protein kinase‑1; PKB: Protein kinase B; F‑actin: Filamentous actin; G‑actin: Globular actin; MST1/2: Mammalian
sterile 20 -like kinase-1/2; homologs of Drosophila Hippo; SAV1: Homolog of Drosophila Salvador; LATS1/2: Mammalian homologs of Drosophila
Warts; YAP: Yes‑associated protein; TAZ: Transcriptional coactivator with PDZbinding motif; TEAD transcriptional factors: Transcription factors containing
the TEA/ATTS DNA binding domain; CCN growth factors – Acronym derived from three of its members: CCN1 (cysteine‑rich angiogenic protein 61),
CCN2 (connective tissue growth factor), and CCN3 (nephroblastoma overexpressed); BIRC apoptosis inhibitors: Baculoviral inhibitors of apoptosis
repeat‑containing proteins.
[5,20]

with a great balance of both quality and quantity. The ideal
isolation approach should allow for harvesting the maximum
number of follicles while causing the minimum damage. There
are two main methods currently in use, mechanical isolation
and enzyme digestion. Mechanical isolation is more often
used to isolate larger follicles[21] as they are visible under the
microscopy. The main advantage of mechanical isolation is
avoidance of detrimental effects caused by enzyme digestion.
However, this strategy comes with some disadvantages. First,
it has relatively low efficiency. Second, it is only capable
232

to isolate large‑sized growing follicles. Finally, it is hard to
remove potential malignant cells during the follicle isolation
when artificial ovary is established and transferred.[22]
Enzyme digestion is widely used for follicle isolation yielding high
numbers of isolated preantral follicles.[23,24] In the earlier studies,
the enzymes used were often collagenases, which were originally
employed for digestion of tissues. However, collagenases
may contain high levels of endotoxins that could significantly
affect culture and grafting outcomes, as shown for pancreatic
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islets.[25] Oocyte exclusion from IVG follicles were observed
often, which may be caused by endotoxicity and overexposure to
the enzymes. Furthermore, collagenases also show a considerable
batch effect when assessing effectiveness.[26] Because of this,
second‑generation enzymes, including LiberaseTM[23] and Liberase
DH,[24] were tested and proved to have a better efficiency and
result in less damage to follicles.[22,27]

Culture systems

Once activation of primordial follicles is accomplished, the
next major challenge for follicular IVG is to ensure growth of
the primary follicle, development of granulosa and theca cells,
and subsequently the development of an atrium.[28] Several
culture strategies have been proposed in different species and
with variable success, each of these with their own advantages
and drawbacks. These techniques can be readily divided into
two major categories: two‑dimensional (2D) and 3D culture
systems.

Two‑dimensional culture systems

The first attempts for follicular culture in mammals were
conducted using 2D culture systems, given its apparent less
complex nature and its similarity with already well‑established
cell culture protocols.[29,30] Moreover, the easiness to monitor
cell development and morphology also makes 2D systems
more appealing than the 3D counterparts, which offer an
environment where visualization of the sample in question
is very much limited.[31] On the other hand, 2D systems come
with several disadvantages, which, unsurprisingly, have
rendered development of most mammalian follicles in vitro
unsuccessful and have only provided promising results in
rodents.[28,29]
Perhaps the most critical of these disadvantages is failure to
maintain the follicular spherical structure. 2D systems behave
like canonical monolayer cell cultures.[32] In fact, it has been
reported that granulosa cells undergo cell growth, leading to
horizontal spread across the culture flask rather than organizing
in a sphere around the germ cell in a multilayer manner.[30] As
a result, pivotal cellular interactions between the oocyte and
granulosa cells are disrupted and further in vitro development
is compromised.[33,34]

Three‑dimensional culture systems

3D culture systems have become the preferred and most
utilized platforms to sustain in vitro follicle culture due to the
challenges mentioned above.[28] As previously discussed, a
system in which the follicular architecture is preserved allows
for undisturbed cellular interactions and for more optimal
follicle development. For instance, a recent study investigated
the potential of a 3D‑printed microporous scaffold to sustain
follicle development and eventually restore ovarian function
in rodents.[35] Briefly, a porous structure made out of gelatin
was designed in which the size of the micropores was carefully
controlled. In addition, when isolated follicles of several stages
were added to the scaffold for in vitro culture, it was noted that
follicle survival and development was significantly enhanced
when the spherical structure of the follicle was maintained.

Although this technology was mainly thought as a bioprosthetic
alternative to restore folliculogenesis in vivo, it indeed offers a
novel approach to be exploited in the in vitro follicle culture field.
Nonetheless, 3D strategies still present some disadvantages that
cannot be ignored. For instance, some commonly use matrices
for 3D culture are too rigid and as a result become resistant to
follicle growth, as seen in rodents.[36,37] In humans, a grown antral
follicle in vivo could reach 10 mm,[38] which means that the ideal
chosen 3D matrix should have either enough elasticity or be prone
to digestion by enzymatic activity from the growing follicle.[39]
In addition, once the follicle has reached an acceptable stage
of development, the 3D structure should be easily dismantled
to retrieve the mature follicle, and many of the currently used
materials for 3D culture cannot effortlessly removed.[37]
Furthermore, another important issue when establishing
3D systems for in vitro follicle culture is selecting the most
appropriate material. Collagen was one of the first materials
used to build matrices for 3D culture due to its abundant
presence in the in vivo extracellular matrix. Although some
attempts have been successful in humans, [40] collagen
comes with the drawback that visibility is highly hampered
for monitoring follicular development, not to mention the
accelerated shrinkage of the gel during prolonged culture.[31]
Moreover, another popular choice for 3D matrix is alginate,
a material of natural origin that in the form of a hydrogel has
provided promising results in culture of human[41] and other
primate follicles.[42,43] Matrigel, on the other hand, is a protein
mixture that when coupled with fibrin renders the system highly
elastic and therefore allows the follicle to expand and increase
in size.[44,45] Finally, other materials available for this kind of
culture systems are polyethylene glycol hydrogels and mixtures
of the aforementioned materials in different ratios.[46‑48]
Although an enormous effort has been made to investigate and
discover the ideal scaffold for follicle culture, it is important
to mention that culture of follicles in V‑bottom‑shaped wells
has also provided very promising results. In fact, a very recent
study reported for the first time the development of metaphase
II oocytes with polar bodies and normal spindles from human
primordial/unilaminar follicles in vitro without the use of any
3‑D matrix, indicating that other alternatives can be followed to
circumvent the challenge of maintaining the in vivo architecture
of the follicle in vitro.[21,28] Nevertheless, it is worth mentioning
that this study should provide additional evidence to make the
claim that all starting follicles were at the primordial stage. This
because the pool of immature follicles cultured in the study
included different stages of development and not only primordial.

Improving In vitro Growth of Human Preantral
Follicles
The selection of the optimal culture system is paramount for
successful culture of human follicles in vitro. Nonetheless,
another very important aspect of in vitro culture beyond
selecting the right scaffold is the culture components, either
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cellular or chemical, that are added to the culture to mimic the
in vivo niche of these follicles.
For instance, addition of follicle‑stimulating hormone (FSH)
in the medium for follicular growth has been widely studied
and optimized in both animal models and humans. Due to
its pivotal role in follicular recruitment and development
in vivo,[49] its presence in in vitro culture systems is perhaps one
of the most obvious strategies to improve preantral follicular
growth. Indeed, the first report of meiotically mature oocytes
after in vitro human follicle culture was obtained with FSH
as part of the culture cocktail.[50] Likewise, another elegant
study on rhesus monkey follicles revealed that although FSH
does improve growth and survival of in vitro growth follicles,
the amounts required in the culture system vary depending on
the developmental stage of the follicle. High levels of FSH
showed to improve follicular growth at early stages, whereas
lower doses resulted optimal to sustained follicular survival
in vitro in later stages of development only.[43]
Moreover, the protein fetuin has also been widely used in
follicle culture systems with the scope of generating serum‑free
media, thus avoiding the presence of undesired contaminates.[28]
For these systems, fetuin has proved to be indispensable for
follicular growth and survival, not to mention for the generation
of meiotically competent oocytes.[43] Furthermore, Telfer et al.
in 2008 reported that addition of Activin results in higher
percentages of antral follicles, average increase of size, and
achievement of morphologically normal oocytes compared to
control medium without this supplement.[51]
In addition, some attempts have been made to enhance 3D
culture systems by combining the use of a scaffold with
coculture with other cell types, following the hypothesis that a
paracrine effect could improve follicle survival and mimic the
niche in the gonads. For instance, a significant benefit in follicle
survival and perfused vasculature was observed after adding
mesenchymal stem cells (MSCs) to cryopreserved human
ovarian cortex transplanted in mice.[52] Due to the improved
follicle survival, the same group also reported that coculture of
human preantral follicles with MSCs increased not only in vitro
survival and growth but also expression of genes vital for proper
folliculogenesis, such as GDF9, BMP15, and Activin A.[53]
Finally, other compounds such as basic fibroblast growth
factor (bFGF) and endothelial growth factor have been tested
in cattle, goats, and felines with significant improvements in
in vitro follicular development.[54‑56] With respect to human
follicle culture, bFGF was added to the culture medium of a
study assessing follicular growth in alginate beads of follicles
isolated from frozen and thawed ovarian tissue compared to
fresh. Follicular survival rates were significantly improved
with the presence of bFGF.[57,58]

Follicle Growth Quality Assessment
There are no standard evaluation criteria for in vitro follicle
development. The ultimate success of the in vitro culture of
234

follicles is determined by whether the grown oocytes derived
can reach the MII stage after IVM and eventually achieve
fertilization, embryo production, and live births. However, it is
also necessary to assess follicular growth efficiency and quality
during the cross sections of IVG procedure. Commonly used
measurements include morphology, viability assays, follicle and
oocyte dimensions, survival rate, growth rates, hormone secretion,
cell signaling, and molecular markers. These measurements help
predict the outcome of in vitro follicle development.
The most basic way to assess follicles is their morphology.
First, follicle growth could be evaluated by increase in diameter
according to the duration of culture. Second, growth into
advanced stages could be assessed according to the criteria of
follicle classification: primordial follicle (an oocyte surrounded
by a single layer of flattened granuloca cells [GCs]), primary
follicle (an oocyte surrounded by a single layer of cuboidal GCs),
secondary follicle (a growing oocyte surrounded by two to five
layers of GCs), and preantral follicle (six or more layers of GCs
or diameter >120 mm).[59,60] Third, the isolated follicles could also
be classified into “healthy” follicles (with a distinct oocyte and
intact basement membrane), “damaged” follicles (with a broken
basement membrane), and “atretic” follicles (with a dark and
intact basement membrane).[61] Follicle atresia or degeneration
occurs when the oocyte within the “healthy” follicle becomes
dark or disappears. Otherwise, the follicles are considered alive.
Moreover, histological evaluation is also another approach to
assess in vitro‑cultured follicles within ovarian tissues. Common
parameters of histological measurements include measuring the
diameter of the follicle, assessing the morphology of the oocyte,
measuring the thickness of the zona pellucida, and checking the
presence of theca cells and the layers of granulosa cells.
Hormone production of the isolated follicle during in vitro
culture can serve as another indicator of follicle growth quality.
Studies showed that estradiol and progesterone levels were
both positively correlated to follicle development.[42] Follicles
become steroidogenically active and entered the antral stage
increasing secretion of the anti‑Mullerian hormone.[62]
Follicle viability is another important parameter to assess
follicle development. The follicle viability test is often
achieved with a live dead stain of calceinAM and Methidium
homodimer‑I. Based on the percentage of dead granulosa cells,
the follicles can be classified into four categories: V1 follicle
(with no dead granulosa cells), V2 follicle (with <10% of dead
granulosa cells), V3 follicle (with 10%–50% of dead granulosa
cells), and V4 follicle (with >50% of dead granulosa cells).[23]
In addition, follicle development can also be evaluated at the
molecular level with gene expression analyses, such as single
cell quantitative real‑time polymerase chain reaction[57] or even
on genome level with RNA‑seq analysis.[63,64]

Conclusion
Human ovarian follicle IVG is a fascinating technique for
fertility preservation as it does not need hormone stimulation,
has a low risk of reintroducting malignant cells in cancer
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patients, and could increase the pool of fertilizable oocytes in
premenopausal and pubertal females. Nonetheless, in human
beings, retrieval of mature oocytes from in vitro‑cultured
follicles is highly inefficient and evidence of their reproductive
competence is lacking. In future studies, the mechanism of
follicle activation and growth should be further investigated
and the efficiency of follicle isolation should be enhanced.
Long‑term culture systems of follicle growth should be
optimized, and health and safety of offspring derived from these
approaches must be monitored to reach clinical translation.
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